Methods and compositions for treating disorders

Details for Australian Patent Application No. 2004232328 (hide)

Owner Epeius Biotechnologies Corporation

Inventors Gordon, Erlinda M.; Hall, Frederick L.

Agent Cullen & Co

Pub. Number AU-B-2004232328

PCT Pub. Number WO2004/093810

Priority 60/464,571 21.04.03 US

Parent 2001234025

Filing date 21 April 2004

Wipo publication date 4 November 2004

Acceptance publication date 2 October 2008

International Classifications

A01N 63/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, animals, e.g. nematodes, or substances produced by, or obtained from micro-organisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/12 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/093810 Priority application(s): WO2004/093810

30 November 2006 Change of Name(s) of Applicant(s), Section 104

  Epeius Biotechnologies Inc The name of the applicant has been changed to Epeius Biotechnologies Corporation

2 October 2008 Application Accepted

  Published as AU-B-2004232328

23 October 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 01 Oct 2008. Address for service in Australia - Cullen & Co Level 26 239 George Street Brisbane QLD 4000

12 February 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 01 Oct 2008

19 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232332-Aquatic surface barriers and methods for culturing seaweed

2004232326-Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases